A case of juvenile amyopathic dermatomyositis with anti-transcription intermediary factor 1-α antibody showing negative anti-TIF1-γ ELISA results: Comment on "Case of pembrolizumab-induced dermatomyositis with anti-transcription intermediary factor 1-γ an
A case of juvenile amyopathic dermatomyositis with anti-transcription intermediary factor 1-α antibody showing negative anti-TIF1-γ ELISA results: Comment on "Case of pembrolizumab-induced dermatomyositis with anti-transcription intermediary factor 1-γ an
复制标题
抗转录中介因子 1-α 抗体呈阴性的青少年无肌病性皮肌炎一例，抗 TIF1-γ ELISA 结果呈阴性：对“抗转录中介因子 1-γ 和派姆单抗诱导的皮肌炎一例”的评论
DOI：
10.1111/1346-8138.16587
复制
发表时间：
2022
期刊：
影响因子：
3.1
通讯作者：
Akiyama M.
中科院分区：
文献类型：
--
作者：
Koizumi H;Muro Y;Imai S;Yamashita Y;Ogawa-Momohara M;Takeichi T;Murakami M;Mitsuma T;Akiyama M.
对这篇文章的评论出现在”作者对”一个青少年无肌病性皮肌炎病例的回复中，该病例的抗转录中间因子1-α抗体显示抗TIF 1-γ ELISA结果阴性：对Mizumaki等人文章的评论。“”J Dermatol. 2023年7月; 50（7）：e228-e229。这是对”Pembrolizumab诱导的皮肌炎伴抗转录中间因子1-γ抗体的病例“的评论。“J Dermatol. 2022年9月; 49（9）：e311-e312。
A comment on this article appears in" Authors' reply to" a case of juvenile amyopathic dermatomyositis with anti-transcription intermediary factor 1-α antibody showing negative anti-TIF1-γ ELISA results: Comment on the article by Mizumaki et al."" J Dermatol. 2023 Jul; 50 (7): e228-e229. This is a comment on" Case of pembrolizumab-induced dermatomyositis with anti-transcription intermediary factor 1-γ antibody." J Dermatol. 2022 Sep; 49 (9): e311-e312.